These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2818711)

  • 21. Trimethoprim-sulfamethoxazole for bacterial meningitis.
    Levitz RE; Quintiliani R
    Ann Intern Med; 1984 Jun; 100(6):881-90. PubMed ID: 6372565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The changing patterns of Campylobacter jejuni/coli in Lagos, Nigeria after ten years.
    Coker AO; Adefeso AO
    East Afr Med J; 1994 Jul; 71(7):437-40. PubMed ID: 7828496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Campylobacter jejuni enteritis in 385 hospitalised patients.
    Bichile LS; Saraswati K; Popat UR; Nanivadekar SA; Deodhar LP
    J Assoc Physicians India; 1992 Mar; 40(3):164-6. PubMed ID: 1634481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus.
    Tee W; Mijch A; Wright E; Yung A
    Clin Infect Dis; 1995 Sep; 21(3):634-8. PubMed ID: 8527556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pattern of antibiotic susceptibility in Campylobacter jejuni isolates of human and poultry origin.
    Senok A; Yousif A; Mazi W; Sharaf E; Bindayna K; Elnima el-A; Botta G
    Jpn J Infect Dis; 2007 Feb; 60(1):1-4. PubMed ID: 17314416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trimethoprim-sulfamethoxazole: an assessment of more than 12 years of use.
    Salter AJ
    Rev Infect Dis; 1982; 4(2):196-236. PubMed ID: 7051224
    [No Abstract]   [Full Text] [Related]  

  • 27. Co-trimoxazole and the thyroid.
    Smellie JM; Bantock HM; Thompson BD
    Lancet; 1982 Jul; 2(8289):96. PubMed ID: 6123827
    [No Abstract]   [Full Text] [Related]  

  • 28. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
    Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
    Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.
    Goodhart GL
    JAMA; 1984 Nov; 252(19):2748-9. PubMed ID: 6333522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulphonamides and trimethoprim.
    Reeves D
    Lancet; 1982 Aug; 2(8294):370-3. PubMed ID: 6124767
    [No Abstract]   [Full Text] [Related]  

  • 31. Campylobacter enteritis in Denver.
    Blaser MJ; Reller LB; Luechtefeld NW; Wang WL
    West J Med; 1982 Apr; 136(4):287-90. PubMed ID: 7090379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocarditis in a patient with Campylobacter infection.
    Reda E; Mansell C
    N Z Med J; 2005 Aug; 118(1221):U1634. PubMed ID: 16138172
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt.
    Mikhail IA; Bourgeois AL; Hyams KC; Podgore JK; Lissner CR; Walz S
    Scand J Infect Dis; 1987; 19(4):479-81. PubMed ID: 3313681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical trial of fosfomycin for Campylobacter enteritis].
    Nogawa T; Takeuchi Y; Watanabe J; Kimura K; Tomii I; Abe T; Watanabe Y; Nakasone K; Fujimori I; Kobayashi Y
    Jpn J Antibiot; 1984 Sep; 37(9):1620-4. PubMed ID: 6512981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal Campylobacter fetus ss jejuni enteritis.
    Vesikari T; Huttunen L; Mäki R
    Acta Paediatr Scand; 1981 Mar; 70(2):261-3. PubMed ID: 7234412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
    Yeldandi V; Strodtman R; Lentino JR
    J Antimicrob Chemother; 1988 Dec; 22(6):873-80. PubMed ID: 3266621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin.
    Hirschl AM; Wolf D; Berger J; Rotter ML
    Zentralbl Bakteriol; 1990 Apr; 272(4):443-7. PubMed ID: 2360966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute colitis caused by Campylobacter fetus ss. jejuni.
    Blaser MJ; Parsons RB; Wang WL
    Gastroenterology; 1980 Mar; 78(3):448-53. PubMed ID: 7351284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children.
    Salazar-Lindo E; Sack RB; Chea-Woo E; Kay BA; Piscoya ZA; Leon-Barua R; Yi A
    J Pediatr; 1986 Aug; 109(2):355-60. PubMed ID: 3488385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enteric infection due to Campylobacter jejuni].
    Zhang C; Zhang XZ
    Zhonghua Yi Xue Za Zhi; 1985 Jun; 65(6):368-70. PubMed ID: 3930026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.